BeStock  

Repligen RGEN

US equityMarket cap rank #1375Medical Instruments & Supplies
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$209.31M+10.9% YoY
Operating profit$12.96M+2.2% YoY
Net profit-$38.43M-357.7% YoY
Diluted EPS-$0.68-361.5% YoY
Free cash flow$37.82M-11.5% YoY
Operating cash flow$43.10M

Revenue, last 8 quarters

$167.5MDec '24$169.2MMar '25$182.4MJun '25$188.8MSep '25$197.9MDec '25$194.3MMar '26$204.1MJun '26$209.3MSep '26

Net profit, last 8 quarters

$-33.9MDec '24$5.8MMar '25$14.9MJun '25$14.9MSep '25$13.3MDec '25$8.3MMar '26$5.0MJun '26$-38.4MSep '26

Diluted EPS by quarter

-0.60Dec '240.10Mar '250.26Jun '250.26Sep '250.23Dec '250.15Mar '260.09Jun '26-0.68Sep '26

Free cash flow by quarter

$29.2MDec '24$10.6MMar '25$21.0MJun '25$42.7MSep '25$17.4MDec '25$23.3MMar '26$26.7MJun '26$37.8MSep '26

Annual revenue

$366.3MFY20$670.5MFY21$801.5MFY22$632.4MFY23$634.4MFY24$738.3MFY25

Profitability & balance sheet

Gross margin53.5%
Operating margin7.6%
Net margin-1.5%
Return on equity-0.6%
Return on assets-0.4%
Return on invested capital0.1%
Current ratio9.88
Liabilities / assets28.5%
Cash & investments$862.98M
Total debt$671.84M
Net cash (debt)$191.14M
Free cash flow / sales13.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Filtration Products$95.57M 45.7%
  • Chromatography products$53.56M 25.6%
  • Proteins products$32.11M 15.3%
  • Process analytics products$27.76M 13.3%
  • Other$271,000.00 0.1%
  • Royalty and other income$44,000.00 0.0%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $209.31M $204.13M $194.26M $738.26M $197.91M
Total Operating Revenue $209.31M $204.13M $194.26M $738.26M $197.91M
Cost of Revenue $98.33M $94.09M $85.97M $352.01M $96.55M
Gross Profit $110.99M $110.04M $108.28M $386.25M $101.36M
Operating Expense $98.03M $91.04M $90.99M $344.69M $89.15M
Selling and Admin Expenses $83.59M $76.62M $76.54M $290.51M $75.23M
Research & Development $14.44M $14.42M $14.46M $54.18M $13.92M
Operating Profit $12.96M $19.00M $17.29M $41.56M $12.21M
Net Non-Operating Interest Income (Expense) -$6.13M -$6.08M -$6.00M -$23.17M -$5.91M
Non-Operating Interest Expense $5.71M $5.66M $5.58M $21.51M $5.50M
Total Other Finance Costs $422,000.00 $421,000.00 $419,000.00 $1.66M $417,000.00
Other Income (Expense) -$33.63M $1.24M -$9.52M $44.00M $12.81M
Gain on Sale of Security $7.00M $6.43M $6.34M $27.57M $6.75M
Special Income (Charges) -$42.54M -$4.92M -$15.11M $13.61M $5.66M
-Less:Restructuring and Mergern & Acquisition $1.26M $5.03M $1.35M -$13.61M -$5.66M
-Less:Impairment of Capital Assets $41.24M – – – –
-Gain on Sale Of Business -$34,000.00 $103,000.00 -$13.76M – –
Other Non-Operating Income (Expenses) $1.91M -$273,000.00 -$750,000.00 $2.82M $403,000.00
Pretax Profit -$26.81M $14.15M $1.77M $62.38M $19.11M
Tax $11.62M $9.15M -$6.56M $13.49M $5.83M
Net Profit -$38.43M $5.01M $8.33M $48.89M $13.29M
Profit from Continuing Operations -$38.43M $5.01M $8.33M $48.89M $13.29M
Net Income to Parent Company -$38.43M $5.01M $8.33M $48.89M $13.29M
Net Income to Common Stockholders -$38.43M $5.01M $8.33M $48.89M $13.29M
Basic EPS -$0.68 $0.09 $0.15 $0.87 $0.24
Diluted EPS -$0.68 $0.09 $0.15 $0.86 $0.23

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $2.93B $2.95B $2.93B $2.95B $2.95B
Total Current Assets $1.24B $1.20B $1.16B $1.14B $1.14B
Cash and Cash Equivalents & Short-Term Investments $862.98M $810.45M $784.53M $767.63M $767.63M
-Cash and Cash Equivalents $726.96M $606.78M $582.65M $566.02M $566.02M
-Short Term Investments $136.02M $203.67M $201.88M $201.61M $201.61M
Receivables $151.24M $157.71M $151.55M $158.59M $158.59M
-Accounts Receivable $151.24M $157.71M $151.55M $158.59M $158.59M
Inventory $182.21M $186.60M $179.26M $170.46M $170.46M
Other Current Assets $45.57M $45.79M $46.02M $27.14M $27.14M
Total Non-Current Assets $1.68B $1.75B $1.77B $1.81B $1.81B
Net PPE $276.03M $283.07M $287.11M $306.15M $306.15M
-Gross PPE $276.03M $283.07M $287.11M $510.03M $510.03M
Goodwill and Other Intangible Assets $1.41B $1.46B $1.48B $1.50B $1.50B
-Goodwill $1.10B $1.10B $1.11B $1.11B $1.11B
-Other Intangible Assets $305.29M $357.62M $368.19M $386.15M $386.15M
Non-Current Deferred Assets $716,000.00 $700,000.00 $1.36M $694,000.00 $694,000.00
Other Non-Current Assets $2.07M $4.05M $5.88M $4.91M $4.91M
Total Liabilities $834.67M $838.15M $825.31M $843.57M $843.57M
Total Current Liabilities $125.69M $132.66M $126.21M $135.83M $135.83M
Payables $28.46M $33.65M $35.55M $33.60M $33.60M
-Accounts Payable $27.70M $33.23M $34.66M $30.01M $30.01M
-Total Tax Payable $763,000.00 $413,000.00 $897,000.00 $3.59M $3.59M
Current Accrued Expenses $25.71M $25.87M $19.77M $20.87M $20.87M
Short-Term Debt and Capital Lease Obligation $20.40M $19.32M $21.07M $21.56M $21.56M
-Current Capital Lease Obligation $20.40M $19.32M $21.07M $21.56M $21.56M
Current Deferred Liabilities $15.79M $19.60M $18.31M $14.61M $14.61M
Other Current Liabilities $2.25M $3.03M $5.23M $5.05M $5.05M
Total Non-Current Liabilities $708.99M $705.49M $699.10M $707.74M $707.74M
Long Term Debt and Capital Lease Obligation $671.84M $671.62M $666.55M $668.39M $668.39M
-Long Term Debt $555.60M $551.05M $546.59M $542.21M $542.21M
-Long Term Capital Lease Obligation $116.25M $120.58M $119.96M $126.18M $126.18M
Non-Current Deferred Liabilities $19.91M $16.78M $15.02M $22.50M $22.50M
Other Non-Current Liabilities $17.23M $17.09M $17.53M $16.86M $16.86M
Total Equity $2.09B $2.11B $2.11B $2.11B $2.11B
Stockholders' Equity $2.09B $2.11B $2.11B $2.11B $2.11B
Capital Stock $567,000.00 $564,000.00 $564,000.00 $563,000.00 $563,000.00
-Common Stock $567,000.00 $564,000.00 $564,000.00 $563,000.00 $563,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.69B $1.66B $1.65B $1.65B $1.65B
Retained Earnings $431.16M $469.59M $464.58M $456.25M $456.25M
Gains/Losses Not Affecting Retained Earnings -$25.61M -$19.79M -$14.31M -$2.53M -$2.53M
Prepaid Assets – – – $13.57M $13.57M
-Accumulated Depreciation – – – -$203.88M -$203.88M

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $43.10M $32.77M $28.30M $117.42M $25.70M
Net cash flow from continuing operations $43.10M $32.77M $28.30M $117.42M $25.70M
Net Income from Continuing Operations -$38.43M $5.01M $8.33M $48.89M $13.29M
Gain/Loss from Continuing Operations -$530,000.00 -$260,000.00 $13.80M – –
Depreciation & Depletion & Amortization $23.83M $23.77M $24.54M $96.96M $24.59M
Deferred Tax $3.83M $2.93M -$7.70M -$3.37M $2.41M
Other Non-Cash Items $3.91M $6.28M $2.90M -$6.79M -$10.66M
Change in Working Capital -$102,000.00 -$12.97M -$21.90M -$50.88M -$24.35M
-Change in Receivables $7.75M -$7.55M $3.19M -$17.17M -$9.86M
-Change in Inventory $4.09M -$8.09M -$12.07M -$14.95M -$9.60M
-Change in Prepaid Assets $2.23M -$3.98M -$1.98M -$7.76M -$2.26M
-Change in Payables and Accrued Expense -$8.55M $12.32M -$6.74M $7.66M $3.12M
-Change in Other Current Assets $22,000.00 $1.87M $26,000.00 -$1.56M $167,000.00
-Change in Other Current Liabilities -$5.64M -$7.54M -$4.33M -$17.12M -$5.91M
Net cash flow from investing $63.99M -$2.09M -$3.99M -$298.47M -$208.74M
Net Cash Flow from Continuing Investing Activities $63.99M -$2.09M -$3.99M -$298.47M -$208.74M
Capital Expenditure -$335,000.00 -$735,000.00 -$237,000.00 -$2.21M -$156,000.00
Net PPE Purchase and Sale -$4.95M -$5.33M -$4.71M -$23.28M -$7.96M
Net Business Purchase and Sale $0.00 $3.64M $0.00 -$70.33M -$374,000.00
Net Investment Purchase and Sale $69.27M -$73,000.00 $1.38M -$200.26M -$200.26M
Financing Cash Flow $14.60M -$6.20M -$5.54M -$15.21M $195,000.00
Net Cash Flow from Continuing Financing Activities $14.60M -$6.20M -$5.54M -$15.21M $195,000.00
Proceeds from Stock Option Exercised $15.76M $94,000.00 $0.00 $3.18M $1.03M
Net Other Financing Charges -$1.15M -$6.29M -$5.54M -$18.38M -$839,000.00
Ending Cash Balance $729.01M $608.81M $584.64M $566.02M $566.02M
Net Change in Cash $121.69M $24.48M $18.76M -$196.26M -$182.85M
Beginning Cash Balance $608.81M $584.64M $566.02M $757.36M $748.75M
Effect of Exchange Rate Changes -$1.49M -$311,000.00 -$145,000.00 $4.93M $119,000.00
Free Cash Flow $37.82M $26.70M $23.35M $91.69M $17.40M
Net Other Investing Changes – – -$416,000.00 -$2.40M $0.00
Net Intangibles Purchase and Sale – – – $0.00 –
Net Issuance Payments Of Debt – – – $0.00 $0.00
Net Common Stock Issuance – – – $0.00 –

Discussion

No comments yet — be the first to weigh in on RGEN.

Sign in to join the discussion.

Scroll to Top